- In vitro and in vivo studies on the development of the alpha-emitting radionuclide bismuth 212 for intraperitoneal use against microscopic ovarian carcinoma. Rotmensch, J., Whitlock, J.L., Schwartz, J.L., Hines, J.J., Reba, R.C., Harper, P.V. Am. J. Obstet. Gynecol. (1997)